Login / Signup
Yajin Chen
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 2
Top Topics
Case Control
Open Label
Metastatic Colorectal Cancer
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yajin Chen
,
Cheng-You Du
,
Shun-Li Shen
,
Wu Zhang
,
Yunfeng Shan
,
Ang Lyu
,
Jianhui Wu
,
Changzhen Shang
,
Xuan Luo
,
Jinxing Wei
,
Heng Xiao
,
Jian-Guo Qiu
,
Yunpeng Hua
,
Shutong Wang
,
Ting Wang
,
Shengjie Dai
,
Shuhao Zhang
,
Bingying Xie
,
Yinghao Wu
,
Chun-Yi Hao
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
30 (14) (2024)
Yajin Chen
,
Cheng-You Du
,
Shun-Li Shen
,
Wu Zhang
,
Yunfeng Shan
,
Ang Lyu
,
Jianhui Wu
,
Changzhen Shang
,
Xuan Luo
,
Jinxing Wei
,
Heng Xiao
,
Jian-Guo Qiu
,
Yunpeng Hua
,
Shutong Wang
,
Ting Wang
,
Shengjie Dai
,
Shuhao Zhang
,
Bingying Xie
,
Yinghao Wu
,
Chun-Yi Hao
Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2024)